Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia

BACKGROUND/AIMS: We evaluated the feasibility and long-term efficacy of the combination of cytarabine, idarubicin, and all-trans retinoic acid (ATRA) for treating patients with newly diagnosed acute promyelocytic leukemia (APL). METHODS: We included 87 patients with newly diagnosed acute myeloid leu...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Young Hoon, Kim, Dae-Young, Mun, Yeung-Chul, Cho, Eun Kyung, Lee, Jae Hoon, Jo, Deog-Yeon, Kim, Inho, Yoon, Sung-Soo, Park, Seon Yang, Kim, Byoungkook, Bang, Soo-Mee, Kim, Hawk, Min, Young Joo, Park, Jae Hoo, Seo, Jong Jin, Moon, Hyung Nam, Lee, Moon Hee, Kim, Chul Soo, Lee, Won Sik, Chong, So Young, Oh, Doyeun, Zang, Dae Young, Lee, Kyung Hee, Hyun, Myung Soo, Kim, Heung Sik, Kim, Sung-Hyun, Kwon, Hyukchan, Kim, Hyo Jin, Park, Kyung Tae, Bae, Sung Hwa, Ryoo, Hun Mo, Choi, Jung Hye, Ahn, Myung-Ju, Yoon, Hwi-Joong, Nam, Sung-Hyun, Kim, Bong-Seog, Seong, Chu-Myong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271710/
https://www.ncbi.nlm.nih.gov/pubmed/35811370
http://dx.doi.org/10.3904/kjim.2021.468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271710/
https://www.ncbi.nlm.nih.gov/pubmed/35811370
http://dx.doi.org/10.3904/kjim.2021.468

Ejemplares similares